Literature DB >> 20369971

An age-structured model of hiv infection that allows for variations in the production rate of viral particles and the death rate of productively infected cells.

Patrick W Nelson1, Michael A Gilchrist, Daniel Coombs, James M Hyman, Alan S Perelson.   

Abstract

Mathematical models of HIV-1 infection can help interpret drug treatment experiments and improve our understanding of the interplay between HIV-1 and the immune system. We develop and analyze an age- structured model of HIV-1 infection that allows for variations in the death rate of productively infected T cells and the production rate of viral particles as a function of the length of time a T cell has been infected. We show that this model is a generalization of the standard differential equation and of delay models previously used to describe HIV-1 infection, and provides a means for exploring fundamental issues of viral production and death. We show that the model has uninfected and infected steady states, linked by a transcritical bifurcation. We perform a local stability analysis of the nontrivial equilibrium solution and provide a general stability condition for models with age structure. We then use numerical methods to study solutions of our model focusing on the analysis of primary HIV infection. We show that the time to reach peak viral levels in the blood depends not only on initial conditions but also on the way in which viral production ramps up. If viral production ramps up slowly, we find that the time to peak viral load is delayed compared to results obtained using the standard (constant viral production) model of HIV infection. We find that data on viral load changing over time is insufficient to identify the functions specifying the dependence of the viral production rate or infected cell death rate on infected cell age. These functions must be determined through new quantitative experiments.

Entities:  

Year:  2004        PMID: 20369971     DOI: 10.3934/mbe.2004.1.267

Source DB:  PubMed          Journal:  Math Biosci Eng        ISSN: 1547-1063            Impact factor:   2.080


  17 in total

1.  Modeling within-host HIV-1 dynamics and the evolution of drug resistance: trade-offs between viral enzyme function and drug susceptibility.

Authors:  Libin Rong; Michael A Gilchrist; Zhilan Feng; Alan S Perelson
Journal:  J Theor Biol       Date:  2007-04-19       Impact factor: 2.691

2.  A multi-scale mathematical modeling framework to investigate anti-viral therapeutic opportunities in targeting HIV-1 accessory proteins.

Authors:  Gajendra W Suryawanshi; Alexander Hoffmann
Journal:  J Theor Biol       Date:  2015-09-16       Impact factor: 2.691

3.  Intracellular transactivation of HIV can account for the decelerating decay of virus load during drug therapy.

Authors:  Christian L Althaus; Rob J De Boer
Journal:  Mol Syst Biol       Date:  2010-02-16       Impact factor: 11.429

4.  Current estimates for HIV-1 production imply rapid viral clearance in lymphoid tissues.

Authors:  Rob J De Boer; Ruy M Ribeiro; Alan S Perelson
Journal:  PLoS Comput Biol       Date:  2010-09-02       Impact factor: 4.475

5.  Mathematical analysis of multiscale models for hepatitis C virus dynamics under therapy with direct-acting antiviral agents.

Authors:  Libin Rong; Alan S Perelson
Journal:  Math Biosci       Date:  2013-05-16       Impact factor: 2.144

6.  Reassessing the human immunodeficiency virus type 1 life cycle through age-structured modeling: life span of infected cells, viral generation time, and basic reproductive number, R0.

Authors:  Christian L Althaus; Anneke S De Vos; Rob J De Boer
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

7.  Implications of decoupling the intracellular and extracellular levels in multi-level models of virus growth.

Authors:  Eric L Haseltine; John Yin; James B Rawlings
Journal:  Biotechnol Bioeng       Date:  2008-11-01       Impact factor: 4.530

Review 8.  Mechanistic Modeling of SARS-CoV-2 and Other Infectious Diseases and the Effects of Therapeutics.

Authors:  Alan S Perelson; Ruian Ke
Journal:  Clin Pharmacol Ther       Date:  2021-03-08       Impact factor: 6.875

9.  Stochastic theory of early viral infection: continuous versus burst production of virions.

Authors:  John E Pearson; Paul Krapivsky; Alan S Perelson
Journal:  PLoS Comput Biol       Date:  2011-02-03       Impact factor: 4.475

10.  Analysis of hepatitis C virus decline during treatment with the protease inhibitor danoprevir using a multiscale model.

Authors:  Libin Rong; Jeremie Guedj; Harel Dahari; Daniel J Coffield; Micha Levi; Patrick Smith; Alan S Perelson
Journal:  PLoS Comput Biol       Date:  2013-03-14       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.